Healthmonix 2021 MBHR Measures

Quality IdMeasure NameHigh PriorityMeasure TypeMeasure Description
MBHR012021 MBHR Measure: Anxiety ScreeningYESProcessThe percentage of adult patients (18 years and older) with an anxiety disorder diagnosis (generalized anxiety disorder, social anxiety disorder, post-traumatic stress disorder, or panic disorder) who have completed a standardized tool (e.g., GAD-7, GAD-2, BAI) during measurement period.View
MBHR022021 MBHR Measure: Anxiety Response at 6-monthsYESPatient Reported Outcome (PRO)The percentage of adult patients (18 years of age or older) with an anxiety disorder (generalized anxiety disorder, social anxiety disorder, post-traumatic stress disorder, or panic disorder) who demonstrated a response to treatment at six months (+/- 60 days) after an index visitView
MBHR032021 MBHR Measure: Pain Interference Response utilizing PROMISYESPatient Reported Outcome (PRO)The percentage of adult patients (18 years of age or older) who report pain issues and demonstrated a response to treatment at one month from the index scoreView
MBHR042021 MBHR Measure: Social Role Functioning Outcome utilizing PROMISYESPatient Reported Outcome (PRO)The percentage of adult patients (18 years of age or older) with a mood or anxiety disorder who report concerns related to their psychosocial function and demonstrated a response to treatment two months (+/- 30 days) after the index visitView
MBHR052021 MBHR Measure: Screening and monitoring for psychosocial problems among children and youthYESPatient Reported Outcome (PRO)Percentage of children from 3.00 to 17.99 years of age who are administered a parent-report, standardized and validated screening tool to assess broad-band psychosocial problems during an intake visit AND who demonstrated a reliable change in parent-reported problem behaviors 2 to 6 months after initial positive screen for externalizing and internalizing behavior problems.View
MBHR062021 MBHR Measure: Sleep Quality Screening and Sleep Response at 3-monthsYESPatient Reported Outcome (PRO)Percentage of patients 18 years and older who reported sleep quality concerns (e.g., insomnia) with documentation of a standardized tool AND demonstrated a response to treatment at three months (+/- 60 days) after index visitView
MBHR072021 MBHR Measure: Posttraumatic Stress Disorder (PTSD) Screening and Outcome AssessmentYESPatient Reported Outcome (PRO)The percentage of patients with a history of a traumatic event (i.e., an experience that was unusually or especially frightening, horrible, or traumatic) who report symptoms consistent with PTSD for at least one month following the traumatic event AND with documentation of a standardized symptom monitor (PCL-5 for adults, CATS for child/adolescent) AND demonstrated a response to treatment at three months (+/- 60 days) after the index visit.

This measure is a multi-strata measure, which addresses symptom monitoring for both child and adult patients being treated for post-traumatic stress symptoms. Assessment instruments monitoring severity of symptoms for PTSD are validated either for adult or child populations. Thus, while the measurement structure will be similar for both populations, the specified instruments for symptom monitoring will be different.
View
MBHR082021 MBHR Measure: Alcohol Use Disorder Outcome ResponseYESPatient Reported Outcome (PRO)The percentage of adult patients (18 years of age or older) who report problems with drinking alcohol AND with documentation of a standardized screening tool (e.g., AUDIT, AUDIT-C, DAST, TAPS) AND demonstrated a response to treatment at three months (+/- 60 days) after the index visitView
MBHR092021 MBHR Measure: Outcome monitoring of ADHD functional impairment in children and youthYESPatient Reported Outcome (PRO)Percentage of children aged 4 through 18 years, with a diagnosis of attention deficit/hyperactivity disorder (ADHD), who demonstrate a change score of 0.25 or greater on the Weiss Functional Impairment Rating Scale - Parent Report (WFIRS-P) within 2 to 6 months after an initial positive finding of functional impairment.View
MBHR102021 MBHR Measure: Symptom Improvement in adults with ADHDYESPatient Reported Outcome (PRO)The percentage of adult patients (18 years of age or older) with a diagnosis of ADHD who show a reduction in symptoms of .25 (25%) on the Adult ADHD Self-Report Scale (ASRS-v1.1 - referred to as ASRS) 18 item self-report scale of ADHD symptoms within 2 to 6 months after initially reporting significant symptomsView
MBHR112021 MBHR Measure: Cognitive Assessment with Counseling on Safety and Potential RiskNOProcessPercentage of patients, regardless of age, referred for evaluation due to concerns for cognitive impairment for whom 1) a standardized valid assessment of cognition was performed and 2) reporting of results included counseling on safety and potential risks.View
MBHR122021 MBHR Measure: Patient Feedback of Test Results Following Cognitive or Mental Status AssessmentYESPatient Experience – ProcessPercentage of patients, regardless of age, who received a standardized cognitive or mental status assessment followed by provision of feedback on test results directly to patient and/or their caregiver.View